Search This Blog

Thursday, February 27, 2020

Nektar Therapeutics EPS beats by $0.03, beats on revenue

Nektar Therapeutics (NASDAQ:NKTR): Q4 GAAP EPS of -$0.64 beats by $0.03.
Revenue of $33.9M (-14.8% Y/Y) beats by $7.16M.
Press Release
https://seekingalpha.com/news/3546723-nektar-therapeutics-eps-beats-0_03-beats-on-revenue
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)